South Dakota bills · 2026 Regular Session

South Dakota HB 1099

reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

1. Introduced
2. In committee
3. Passed House
4. Passed Senate
5. To Governor
6. Became law

Sponsors

• Wittman (Democratic)
• Wipf (Republican)
• Uhre-Balk (Democratic)
• Perry (Republican)
• Mulder (Republican)
• Muckey (Democratic)
• Moore (Republican)
• Heermann (Republican)
• Goodwin (Republican)
• Emery (Democratic)
• Davis (Republican)
• Rehfeldt (Republican)
• Pischke (Republican)

Summary

Text versions

• Enrolled· Mar 3, 2026
• Introduced· Jan 20, 2026

Roll-call votes

State vote data last updated Oct 15, 2026, 4:08 AM.

Actions

• Mar 10, 2026
  Signed by the Governor on 2026-03-10 H.J. 547
• Mar 5, 2026 · Senate
  Delivered to the Governor on 2026-03-05 H.J. 520
• Mar 4, 2026 · Senate
  Signed by the President S.J. 470
• Mar 3, 2026 · Senate
  Signed by the Speaker H.J. 492
• Mar 2, 2026 · Senate
  Senate Do Pass , Passed, YEAS 21, NAYS 12 S.J. 429
• Feb 26, 2026 · Senate
  Remove from Consent Calendar S.J. 412
• Feb 25, 2026 · Senate
  Certified uncontested, placed on consent , Passed, S.J. 21
• Feb 25, 2026 · Senate
  Health and Human Services Do Pass , Passed, YEAS 6, NAYS 0 S.J. 21
• Feb 25, 2026 · Senate
  Scheduled for hearing S.J. 1
• Feb 10, 2026 · Senate
  First read in Senate and referred to Senate Health and Human Services S.J. 232
• Feb 9, 2026 · House
  House of Representatives Do Pass , Passed, YEAS 58, NAYS 7 H.J. 265
• Feb 5, 2026 · House
  Health and Human Services Do Pass , Passed, YEAS 13, NAYS 0 H.J. 13
• Feb 5, 2026 · House
  Scheduled for hearing H.J. 1
• Jan 21, 2026 · House
  First read in House and referred to House Health and Human Services H.J. 104